ISRCTN03930168已完成不适用
Efficacy of EPs 7630 in acute non-streptococcal tonsillopharyngitis
ISO Arzneimittel GmbH & Co KG (Germany)0 个研究点目标入组 60 人开始时间: 2002年6月14日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •The study took place between March and April 1997. It is terminated. Patients, who met the following inclusion criteria, were suitable for the trial:
- •1. Age 6-10 years
- •2. Acute exsudative tonsillopharyngitis
- •3. Duration of symptoms less than 48 h
- •4. No Group A Beta Hemolytic Streptococcus (GABHS)-infection
- •5. Tonsillopharyngitis Severity Score (TSS) 6 or more points, and
- •6. Informed consent in writing by legal guardians who were able to understand the nature, meaning and consequences of the trial
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Efficacy of EPs 7630 in children with acute non-streptococcal tonsillopharyngitisAcute tonsillopharyngitisRespiratoryTonsillopharyngitisISRCTN86579667ISO Arzneimittel GmbH & Co KG (Germany)78
已完成
不适用
Efficacy of EPs 7630 compared to placebo in the treatment of acute bronchitisBronchitisAcute bronchitisRespiratoryISRCTN60790910ISO Arzneimittel GmbH & Co KG (Germany)205
进行中（未招募）
不适用
Efficacy and tolerability of EPs® 7630 solution in patients (>=18 years old) with Acute Rhinopharyngitis (ARP)Adult patients suffering from acute Rhinopharyngitis.EUCTR2007-005579-33-BGDr. Willmar Schwabe GmbH &Co. KG
已完成
不适用
Efficacy of EPs 7630 compared to placebo in children with acute non-streptococcal tonsillopharyngitisAcute tonsillopharyngitisRespiratoryTonsillopharyngitisISRCTN27398531ISO Arzneimittel GmbH & Co KG (Germany)124
已完成
不适用
Safety and intake effect of EPs® 7630 (an extract of the roots of Pelargonium sidoides)Common coldISRCTN35425744Dr. Willmar Schwabe GmbH & Co. KG (Germany)798